Biodesix Inc (BDSX) stock
BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$9.88+0.09 (+0.92%)
Close on Nov 13, 2026Market cap $104.25MP/E –Yield –
Biodesix enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Biodesix's enterprise value was $123.59M on Nov 11, 2026, against $96.28M a year earlier. Over the last 5 years it ranged from $84.51M to $5.68B, with a median of $1.49B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $123.59M | +46.2% |
| 2025 | Dec 31, 2025 | $84.51M | -98.1% |
| 2024 | Dec 31, 2024 | $4.46B | +36.9% |
| 2023 | Dec 29, 2023 | $3.26B | +72.8% |
| 2022 | Dec 30, 2022 | $1.88B | -33.7% |
| 2021 | Dec 31, 2021 | $2.84B | +2129.1% |
| 2020 | Dec 31, 2020 | $127.44M | – |
See a number that looks wrong?